These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1897376)

  • 1. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
    Berger M; Riemann D; Krieg C
    Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.
    Riemann D; Hohagen F; Bahro M; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(5):279-90. PubMed ID: 8172943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders.
    Schreiber W; Lauer CJ; Krumrey K; Holsboer F; Krieg JC
    Biol Psychiatry; 1992 Jul; 32(1):79-90. PubMed ID: 1391297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives.
    Krieg JC; Berger M
    Acta Psychiatr Scand; 1987 Nov; 76(5):600-2. PubMed ID: 3434333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of RS 86 on REM latency in schizophrenia.
    Riemann D; Gann H; Fleckenstein P; Hohagen F; Olbrich R; Berger M
    Psychiatry Res; 1991 Jul; 38(1):89-92. PubMed ID: 1946836
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of the muscarinic agonist RS 86 on the cortisol system.
    Krieg JC; Bossert S; Pirke KM; von Zerssen D; Berger M
    Biol Psychiatry; 1987 May; 22(5):573-82. PubMed ID: 3580432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic REM sleep induction response correlation with endogenous major depressive subtype.
    Jones D; Kelwala S; Bell J; Dube S; Jackson E; Sitaram N
    Psychiatry Res; 1985 Feb; 14(2):99-110. PubMed ID: 3857656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic neurotransmission, REM sleep and depression.
    Riemann D; Hohagen F; Bahro M; Lis S; Stadmüller G; Gann H; Berger M
    J Psychosom Res; 1994; 38 Suppl 1():15-25. PubMed ID: 7799246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
    Riemann D; Hohagen F; Fritsch-Montero R; Krieger S; Gann H; Dressing H; Muller W; Berger M
    Acta Psychiatr Belg; 1992; 92(3):151-71. PubMed ID: 1345430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
    Berger M; Riemann D; Höchli D; Spiegel R
    Arch Gen Psychiatry; 1989 May; 46(5):421-8. PubMed ID: 2712660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
    Dilsaver SC
    J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep, age, depression and the cholinergic REM induction test with RS 86.
    Riemann D; Berger M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):311-6. PubMed ID: 1589588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
    Riemann D; Joy D; Höchli D; Lauer C; Zulley J; Berger M
    Psychiatry Res; 1988 May; 24(2):137-47. PubMed ID: 3406234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulation.
    Gann H; Riemann D; Hohagen F; Dressing H; Müller WE; Berger M
    J Affect Disord; 1992 Nov; 26(3):179-89. PubMed ID: 1460168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic-cholinergic balance and the treatment of affective disorders.
    Janowsky DS; Risch SC; Gillin JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):297-307. PubMed ID: 6684317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression.
    Steiger A; Guldner J; Colla-Müller M; Friess E; Sonntag A; Schier T
    J Psychiatr Res; 1994; 28(3):225-38. PubMed ID: 7932284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep.
    Foster NL; Aldrich MS; Bluemlein L; White RF; Berent S
    Neurology; 1989 Feb; 39(2 Pt 1):257-61. PubMed ID: 2644580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86.
    Riemann D; Berger M
    Neuropsychopharmacology; 1989 Jun; 2(2):145-52. PubMed ID: 2742728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression.
    Poland RE; Tondo L; Rubin RT; Trelease RB; Lesser IM
    Biol Psychiatry; 1989 Feb; 25(4):403-12. PubMed ID: 2930809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.